Go back

Your message has been sent

SURVEY – DOLPHIN CPAP

Dear Colleague, this is a short survey to assess your opinion about the use of the Dolphin CPAP in your neonatal intensive care unit (NICU). The participation in the survey takes about 5 minutes of your time.

A. General Information

B. Device Performance

5. FiO₂ is stable during use(required)
6. Overall clinical performance is as intended use(required)

C. Usability & Alarms

7. Device is easy to setup and operate(required)
8. Alarms are clear and useful(required)
9. Instructions for Use (IFU) are clear(required)
10. Cleaning and maintenance is easy(required)

D. Safety

11. Have you observed any unexpected side effects during use?(required)
12. Have you encountered any device malfunctions?(required)

E. Misuse / Off-Label Use

13. Have you observed any misuse?(required)
14. Have you observed off-label use?(required)

F. Clinical Benefit

NOTE: Following questions should base on your general clinical observations of therapy. Patient data or measured outcomes are not requested.

15. Do neonates typically show improved oxygenation (SpO₂ 89–96%) within the first 24 hours of Dolphin CPAP therapy?(required)
16. In your clinical observation, does the patient’s Respiratory Severity Score (RSS) generally improve within the first 24 hours of Dolphin CPAP therapy?(required)

If available, please record representative cases below:

PATIENT 1

Silverman

FiO₂

SpO₂

PATIENT 2

Silverman

FiO₂

SpO₂

 

 

Copyright © 2004-2026 MTTS. All rights reserved.